Across TCGA pan-cancer cohorts, ZNF703 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ZNF703 data layer compared with 25 for mass-spec protein and 7 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher ZNF703 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF703 expression acts as an unfavorable survival marker.

ESCA and DLBC are the cancer types where ZNF703 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.162	0.707	<.001	36	view →
DLBC	OS	Median	All	0.054	0.842	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: ZNF703 tumor-vs-normal RNA expression · all ZNF703 data types